Clinical Chemistry, ISSN 0009-9147, 01/2014, Volume 60, Issue 1, pp. 233 - 242
BACKGROUND: Carboxypeptidase N(CPN) is important in regulating vasoactive peptide hormones, growth factors, and cytokines by specifically cleaving their...
BIOMARKERS | PEPTIDOME | PROTEIN | KININASE-I | TISSUE | ENRICHMENT | MEDICAL LABORATORY TECHNOLOGY | IDENTIFICATION | ANGIOTENSIN-CONVERTING ENZYME | TUMOR MICROENVIRONMENT | BRADYKININ | Peptides - blood | Peptides - antagonists & inhibitors | Early Detection of Cancer | Humans | Tumor Microenvironment | Biomarkers, Tumor - blood | Breast Neoplasms - enzymology | Animals | Peptidomimetics | Lysine Carboxypeptidase - metabolism | Female | Breast Neoplasms - diagnosis | Mice | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Biomarkers, Tumor - antagonists & inhibitors | Disease Models, Animal | Lysine Carboxypeptidase - blood | Protein research | Proteolysis | Proteases | Oncology, Experimental | Breast cancer | Research | Diagnosis | Health aspects | Methods | Cancer | Proteins | Studies | Biomarkers | Enzymes | Peptides | Carboxypeptidase N | Circulating peptides | Nanopore-based assay | Early detection
BIOMARKERS | PEPTIDOME | PROTEIN | KININASE-I | TISSUE | ENRICHMENT | MEDICAL LABORATORY TECHNOLOGY | IDENTIFICATION | ANGIOTENSIN-CONVERTING ENZYME | TUMOR MICROENVIRONMENT | BRADYKININ | Peptides - blood | Peptides - antagonists & inhibitors | Early Detection of Cancer | Humans | Tumor Microenvironment | Biomarkers, Tumor - blood | Breast Neoplasms - enzymology | Animals | Peptidomimetics | Lysine Carboxypeptidase - metabolism | Female | Breast Neoplasms - diagnosis | Mice | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Biomarkers, Tumor - antagonists & inhibitors | Disease Models, Animal | Lysine Carboxypeptidase - blood | Protein research | Proteolysis | Proteases | Oncology, Experimental | Breast cancer | Research | Diagnosis | Health aspects | Methods | Cancer | Proteins | Studies | Biomarkers | Enzymes | Peptides | Carboxypeptidase N | Circulating peptides | Nanopore-based assay | Early detection
Journal Article
Microbiology and Immunology, ISSN 0385-5600, 02/2002, Volume 46, Issue 2, pp. 131 - 134
Pro‐carboxypeptidase R (proCPR), also known as thrombin‐activatable fibrinolysis inhibitor (TAFI), precursor of carboxypeptidase U and plasma carboxypeptidase...
complement | inflammation | anaphylatoxin | carboxypeptidase | Carboxypeptidase | Complement | Inflammation | Anaphylatoxin | ACTIVATION | PROTEIN | MICROBIOLOGY | IMMUNOLOGY | ALTERNATIVE COMPLEMENT PATHWAY | PLASMA CARBOXYPEPTIDASE | Complement C5a - antagonists & inhibitors | Hydrolysis | Carboxypeptidase B2 - pharmacology | Time Factors | Complement C3a - antagonists & inhibitors | Humans | Carboxypeptidase B2 - blood | Lysine Carboxypeptidase - pharmacology | Lysine Carboxypeptidase - blood
complement | inflammation | anaphylatoxin | carboxypeptidase | Carboxypeptidase | Complement | Inflammation | Anaphylatoxin | ACTIVATION | PROTEIN | MICROBIOLOGY | IMMUNOLOGY | ALTERNATIVE COMPLEMENT PATHWAY | PLASMA CARBOXYPEPTIDASE | Complement C5a - antagonists & inhibitors | Hydrolysis | Carboxypeptidase B2 - pharmacology | Time Factors | Complement C3a - antagonists & inhibitors | Humans | Carboxypeptidase B2 - blood | Lysine Carboxypeptidase - pharmacology | Lysine Carboxypeptidase - blood
Journal Article
Clinica Chimica Acta, ISSN 0009-8981, 03/2008, Volume 389, Issue 1-2, pp. 181 - 182
Carboxypeptidase N | Angio-oedema | Inflammation | ACE inhibitors | Deficiency | TAFI | carboxypeptidase N | PLASMA | ASSAY | deficiency | inflammation | SERUM | MEDICAL LABORATORY TECHNOLOGY | angio-oedema | PROCARBOXYPEPTIDASE-U TAFI | Reference Values | Reference Standards | Humans | Lysine Carboxypeptidase - deficiency | Lysine Carboxypeptidase - blood
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2008, Volume 121, Issue 2, pp. 429 - 433
Background Aminopeptidase P (APP) plays an important role in the catabolism of kinins in human plasma, mostly for des-Arg9 -bradykinin. Impaired degradation of...
Allergy and Immunology | des-Arg 9-bradykinin | androgen | Hereditary angioedema | danazol | stanozolol | C1 inhibitor | bradykinin | aminopeptidase P | des-Arg | SYSTEM | ACE | ENDOGENOUS KININS | IMMUNOLOGY | PATHOPHYSIOLOGY | hereditary angioedema | ALLERGY | EDEMA | INFLAMMATION | des-Arg-bradykinin | INHIBITORS | RECEPTORS | Severity of Illness Index | Kinins - metabolism | Prospective Studies | Humans | Middle Aged | Aminopeptidases - blood | Angioedemas, Hereditary - prevention & control | Metabolism | Peptidyl-Dipeptidase A - blood | Metalloproteases - blood | Aged, 80 and over | Adult | Androgens - therapeutic use | Aged | Complement C1 Inhibitor Protein - metabolism | Angioedemas, Hereditary - blood | Angioedemas, Hereditary - physiopathology | Lysine Carboxypeptidase - blood | Drug therapy | Angioneurotic edema | Studies | Plasma | Ligands | Androgens | Patients | Rodents | Metalloproteases | Angioedema, Hereditary | Health | Aminopeptidases | Kinins | Peptidyl-Dipeptidase A | Complement C1 Inhibitor Protein | Life Sciences | Ecology, environment | Lysine Carboxypeptidase | des-Arg9-bradykinin
Allergy and Immunology | des-Arg 9-bradykinin | androgen | Hereditary angioedema | danazol | stanozolol | C1 inhibitor | bradykinin | aminopeptidase P | des-Arg | SYSTEM | ACE | ENDOGENOUS KININS | IMMUNOLOGY | PATHOPHYSIOLOGY | hereditary angioedema | ALLERGY | EDEMA | INFLAMMATION | des-Arg-bradykinin | INHIBITORS | RECEPTORS | Severity of Illness Index | Kinins - metabolism | Prospective Studies | Humans | Middle Aged | Aminopeptidases - blood | Angioedemas, Hereditary - prevention & control | Metabolism | Peptidyl-Dipeptidase A - blood | Metalloproteases - blood | Aged, 80 and over | Adult | Androgens - therapeutic use | Aged | Complement C1 Inhibitor Protein - metabolism | Angioedemas, Hereditary - blood | Angioedemas, Hereditary - physiopathology | Lysine Carboxypeptidase - blood | Drug therapy | Angioneurotic edema | Studies | Plasma | Ligands | Androgens | Patients | Rodents | Metalloproteases | Angioedema, Hereditary | Health | Aminopeptidases | Kinins | Peptidyl-Dipeptidase A | Complement C1 Inhibitor Protein | Life Sciences | Ecology, environment | Lysine Carboxypeptidase | des-Arg9-bradykinin
Journal Article
Analytical Biochemistry, ISSN 0003-2697, 2006, Volume 356, Issue 1, pp. 157 - 159
CHEMISTRY, ANALYTICAL | ACTIVATION | SERUM | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | Blood Chemical Analysis - methods | Humans | Carboxypeptidase B2 - blood | Substrate Specificity | Kinetics | Dipeptides - chemistry | In Vitro Techniques | Lysine Carboxypeptidase - blood | Enzymes
Journal Article
6.
Full Text
Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator
International Immunopharmacology, ISSN 1567-5769, 2007, Volume 7, Issue 14, pp. 1888 - 1899
Human carboxypeptidase N (CPN) was discovered in the early 1960s as a plasma enzyme that inactivates bradykinin and was identified 8 years later as the major...
Anaphylatoxins | Human carboxypeptidase N | Proteolysis | Protein structure | Bradykinin | Plasmin | PROTEIN | KININASE-I | I-CONVERTING-ENZYME | CRYSTAL-STRUCTURE | bradykinin | IMMUNOLOGY | PROTAMINE REVERSAL | human carboxypeptidase N | protein structure | ACTIVE SUBUNIT | NITRIC-OXIDE PRODUCTION | plasmin | anaphylatoxins | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | B-1 RECEPTORS | proteolysis | CREATINE-KINASE | Protein Structure, Tertiary | Sequence Homology, Amino Acid | Amino Acid Sequence | Lysine Carboxypeptidase - chemistry | Lysine Carboxypeptidase - genetics | Humans | Models, Molecular | Crystallography, X-Ray | Structure-Activity Relationship | Amino Acid Motifs | Lysine Carboxypeptidase - blood | Physiological aspects
Anaphylatoxins | Human carboxypeptidase N | Proteolysis | Protein structure | Bradykinin | Plasmin | PROTEIN | KININASE-I | I-CONVERTING-ENZYME | CRYSTAL-STRUCTURE | bradykinin | IMMUNOLOGY | PROTAMINE REVERSAL | human carboxypeptidase N | protein structure | ACTIVE SUBUNIT | NITRIC-OXIDE PRODUCTION | plasmin | anaphylatoxins | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | B-1 RECEPTORS | proteolysis | CREATINE-KINASE | Protein Structure, Tertiary | Sequence Homology, Amino Acid | Amino Acid Sequence | Lysine Carboxypeptidase - chemistry | Lysine Carboxypeptidase - genetics | Humans | Models, Molecular | Crystallography, X-Ray | Structure-Activity Relationship | Amino Acid Motifs | Lysine Carboxypeptidase - blood | Physiological aspects
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 06/1994, Volume 269, Issue 22, pp. 15937 - 15944
A novel basic carboxypeptidase clearly different from carboxypeptidase N has been isolated from human plasma. It circulates as an enzymatically inactive...
HUMAN-SERUM | CATALYZED HYDROLYSIS | ACTIVATOR | MECHANISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | PURIFICATION | ANAPHYLATOXIN | TERMINAL LYSINE | BINDING-SITES | CREATINE-KINASE | FIBRIN | Amino Acid Sequence | Chromatography, Ion Exchange | Lysine Carboxypeptidase - isolation & purification | Molecular Weight | Humans | Enzyme Stability | Molecular Sequence Data | Substrate Specificity | Plasminogen - metabolism | Macromolecular Substances | Peptide Fragments - chemistry | Chromatography, Affinity | Carboxypeptidases - blood | Carboxypeptidase B2 | Carboxypeptidases - chemistry | Kinetics | Chromatography, Gel | Binding Sites | Carboxypeptidases - isolation & purification
HUMAN-SERUM | CATALYZED HYDROLYSIS | ACTIVATOR | MECHANISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | PURIFICATION | ANAPHYLATOXIN | TERMINAL LYSINE | BINDING-SITES | CREATINE-KINASE | FIBRIN | Amino Acid Sequence | Chromatography, Ion Exchange | Lysine Carboxypeptidase - isolation & purification | Molecular Weight | Humans | Enzyme Stability | Molecular Sequence Data | Substrate Specificity | Plasminogen - metabolism | Macromolecular Substances | Peptide Fragments - chemistry | Chromatography, Affinity | Carboxypeptidases - blood | Carboxypeptidase B2 | Carboxypeptidases - chemistry | Kinetics | Chromatography, Gel | Binding Sites | Carboxypeptidases - isolation & purification
Journal Article
The Journal of Immunology, ISSN 0022-1767, 07/2000, Volume 165, Issue 2, pp. 1053 - 1058
Carboxypeptidase R (EC 3.4.17.20; CPR) and carboxypeptidase N (EC 3.4.17.3; CPN) cleave carboxyl-terminal arginine and lysine residues from biologically active...
HUMAN-SERUM | FIBRINOLYSIS | THROMBOMODULIN | PLASMA PROCARBOXYPEPTIDASE-B | ARGININE CARBOXYPEPTIDASE | TAFI | PURIFICATION | COAGULATION | SUBUNITS | ANAPHYLATOXIN | IMMUNOLOGY | Liver - enzymology | Humans | Lipopolysaccharides - administration & dosage | Enzyme Precursors - genetics | Molecular Sequence Data | Male | Acute-Phase Proteins - genetics | Organ Specificity - genetics | RNA, Messenger - biosynthesis | Lysine Carboxypeptidase - genetics | Carboxypeptidases - blood | Base Sequence | Cloning, Molecular | Carboxypeptidase B2 | Lysine Carboxypeptidase - biosynthesis | Amino Acid Sequence | Acute-Phase Proteins - metabolism | Gene Expression Regulation - immunology | Enzyme Precursors - biosynthesis | Injections, Intraperitoneal | Carboxypeptidases - genetics | DNA, Complementary - isolation & purification | Enzyme Precursors - metabolism | Animals | Lysine Carboxypeptidase - metabolism | Carboxypeptidases - biosynthesis | Carboxypeptidases - metabolism | Mice | Mice, Inbred BALB C | Kinetics | Acute-Phase Proteins - biosynthesis
HUMAN-SERUM | FIBRINOLYSIS | THROMBOMODULIN | PLASMA PROCARBOXYPEPTIDASE-B | ARGININE CARBOXYPEPTIDASE | TAFI | PURIFICATION | COAGULATION | SUBUNITS | ANAPHYLATOXIN | IMMUNOLOGY | Liver - enzymology | Humans | Lipopolysaccharides - administration & dosage | Enzyme Precursors - genetics | Molecular Sequence Data | Male | Acute-Phase Proteins - genetics | Organ Specificity - genetics | RNA, Messenger - biosynthesis | Lysine Carboxypeptidase - genetics | Carboxypeptidases - blood | Base Sequence | Cloning, Molecular | Carboxypeptidase B2 | Lysine Carboxypeptidase - biosynthesis | Amino Acid Sequence | Acute-Phase Proteins - metabolism | Gene Expression Regulation - immunology | Enzyme Precursors - biosynthesis | Injections, Intraperitoneal | Carboxypeptidases - genetics | DNA, Complementary - isolation & purification | Enzyme Precursors - metabolism | Animals | Lysine Carboxypeptidase - metabolism | Carboxypeptidases - biosynthesis | Carboxypeptidases - metabolism | Mice | Mice, Inbred BALB C | Kinetics | Acute-Phase Proteins - biosynthesis
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 1995, Volume 96, Issue 5, pp. 2534 - 2538
Carboxy-terminal lysine residues on the surface of cells and fibrin bind plasminogen and control its activation. Since plasma contains basic carboxypeptidases,...
fibrinolysis | thrombolysis | plasminogen activation | plasminogen receptors | MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | RECEPTOR | PLASMINOGEN ACTIVATION | FIBRINOLYSIS | ACTIVATOR | LYSINES | THROMBOLYSIS | BINDING | FIBRINOGEN | PLASMINOGEN RECEPTORS | UROKINASE | SURFACES
fibrinolysis | thrombolysis | plasminogen activation | plasminogen receptors | MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | RECEPTOR | PLASMINOGEN ACTIVATION | FIBRINOLYSIS | ACTIVATOR | LYSINES | THROMBOLYSIS | BINDING | FIBRINOGEN | PLASMINOGEN RECEPTORS | UROKINASE | SURFACES
Journal Article
The Lancet, ISSN 0140-6736, 06/2002, Volume 359, Issue 9323, pp. 2088 - 2089
Angio-oedema is a rare but potentially life threatening side-effect of angiotensin-converting-enzyme (ACE) inhibitor treatment. Identification of individuals...
CONVERTING ENZYME-INHIBITOR | MEDICINE, GENERAL & INTERNAL | PLASMA | BRADYKININ | Humans | Middle Aged | Aminopeptidases - blood | Hypertension - drug therapy | Case-Control Studies | Angioedema - enzymology | Analysis of Variance | Angioedema - blood | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Angioedema - chemically induced | Aged | Lysine Carboxypeptidase - blood | Adverse and side effects | Angioneurotic edema | ACE inhibitors | Risk factors | Hypertension | Enzymes | Plasma | Side effects | Pharmacology | Drug therapy | Edema | Medical research | Patients | Inhibitors | Peptidyl-dipeptidase A | Bradykinin | Angiotensin | Lysine carboxypeptidase | Aminopeptidase
CONVERTING ENZYME-INHIBITOR | MEDICINE, GENERAL & INTERNAL | PLASMA | BRADYKININ | Humans | Middle Aged | Aminopeptidases - blood | Hypertension - drug therapy | Case-Control Studies | Angioedema - enzymology | Analysis of Variance | Angioedema - blood | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Angioedema - chemically induced | Aged | Lysine Carboxypeptidase - blood | Adverse and side effects | Angioneurotic edema | ACE inhibitors | Risk factors | Hypertension | Enzymes | Plasma | Side effects | Pharmacology | Drug therapy | Edema | Medical research | Patients | Inhibitors | Peptidyl-dipeptidase A | Bradykinin | Angiotensin | Lysine carboxypeptidase | Aminopeptidase
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 04/2000, Volume 278, Issue 4, pp. 1069 - 1074
Because bradykinin (BK) appears to have cardioprotective effects ranging from improved hemodynamics to antiproliferative effects, inhibition of BK-degrading...
Kininase I | Peptides | Kininase II | MYOCARDIUM | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | RAT | peptides | KININASE-II | kininase II | HEART | RESPONSES | kininase I | DEGRADATION | PERIPHERAL VASCULAR DISEASE | INHIBITORS | RECEPTORS | BLOOD | Amino Acid Sequence | 3-Mercaptopropionic Acid - analogs & derivatives | Captopril - pharmacology | Bradykinin - chemistry | Humans | Middle Aged | Male | Tritium | Bradykinin - antagonists & inhibitors | Enzyme Activation - drug effects | Blood Proteins - pharmacology | 3-Mercaptopropionic Acid - pharmacology | Protease Inhibitors - pharmacology | Peptidyl-Dipeptidase A - blood | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Bradykinin - blood | Lysine Carboxypeptidase - blood
Kininase I | Peptides | Kininase II | MYOCARDIUM | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | RAT | peptides | KININASE-II | kininase II | HEART | RESPONSES | kininase I | DEGRADATION | PERIPHERAL VASCULAR DISEASE | INHIBITORS | RECEPTORS | BLOOD | Amino Acid Sequence | 3-Mercaptopropionic Acid - analogs & derivatives | Captopril - pharmacology | Bradykinin - chemistry | Humans | Middle Aged | Male | Tritium | Bradykinin - antagonists & inhibitors | Enzyme Activation - drug effects | Blood Proteins - pharmacology | 3-Mercaptopropionic Acid - pharmacology | Protease Inhibitors - pharmacology | Peptidyl-Dipeptidase A - blood | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Bradykinin - blood | Lysine Carboxypeptidase - blood
Journal Article
Analytical Biochemistry, ISSN 0003-2697, 2010, Volume 396, Issue 1, pp. 152 - 154
To date, several assays for procarboxypeptidase U (proCPU) determination exist, all having their own inherent disadvantages and advantages. A drawback of...
CHEMISTRY, ANALYTICAL | ISCHEMIC-STROKE PATIENTS | THRESHOLD | CARBOXYPEPTIDASE-N | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | RISK | THROMBOLYTIC THERAPY | TAFIA | Reference Standards | Humans | Carboxypeptidase B2 - blood | Enzyme Assays - methods | Substrate Specificity | Calibration | Chromatography, High Pressure Liquid | Lysine Carboxypeptidase - blood | Peptides | Liquid chromatography
CHEMISTRY, ANALYTICAL | ISCHEMIC-STROKE PATIENTS | THRESHOLD | CARBOXYPEPTIDASE-N | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | RISK | THROMBOLYTIC THERAPY | TAFIA | Reference Standards | Humans | Carboxypeptidase B2 - blood | Enzyme Assays - methods | Substrate Specificity | Calibration | Chromatography, High Pressure Liquid | Lysine Carboxypeptidase - blood | Peptides | Liquid chromatography
Journal Article
Kidney International, ISSN 0085-2538, 02/2002, Volume 61, Issue 2, pp. 490 - 501
Effects of human soluble thrombomodulin on experimental glomerulonephritis. Coagulation and inflammation are both important processes that contribute to...
kidney | thrombin | glomerular injury | inflammation | anticoagulant | anaphylatoxin | carboxypeptidase | Glomerular injury | Thrombin | Anticoagulant | Carboxypeptidase | Inflammation | Anaphylatoxin | Kidney | CRESCENTIC GLOMERULONEPHRITIS | THROMBIN-CATALYZED ACTIVATION | RHS-TM | PLASMA PROCARBOXYPEPTIDASE-B | GLOMERULAR THROMBOSIS | PULMONARY VASCULAR INJURY | NEPHROTOXIC SERUM | PROTEIN-C ACTIVATION | CARBOXYPEPTIDASE-N | DISSEMINATED INTRAVASCULAR COAGULATION | UROLOGY & NEPHROLOGY | Thrombosis - chemically induced | Rats, Wistar | Thrombosis - complications | Blood Urea Nitrogen | Humans | Prothrombin Time | Carboxypeptidase B2 - blood | Complement C5a - metabolism | Blood Coagulation | Kidney Glomerulus - metabolism | Female | Leukocyte Count | Glomerulonephritis - etiology | Disease Models, Animal | Lysine Carboxypeptidase - blood | Rabbits | Thrombomodulin - administration & dosage | Solubility | Rats | Kidney Glomerulus - pathology | Glomerulonephritis - drug therapy | Thrombosis - pathology | Animals | Platelet Count | Partial Thromboplastin Time | Anaphylatoxins - metabolism | Glomerulonephritis - pathology | Creatinine - blood | Thrombin - metabolism | Fibrin - metabolism
kidney | thrombin | glomerular injury | inflammation | anticoagulant | anaphylatoxin | carboxypeptidase | Glomerular injury | Thrombin | Anticoagulant | Carboxypeptidase | Inflammation | Anaphylatoxin | Kidney | CRESCENTIC GLOMERULONEPHRITIS | THROMBIN-CATALYZED ACTIVATION | RHS-TM | PLASMA PROCARBOXYPEPTIDASE-B | GLOMERULAR THROMBOSIS | PULMONARY VASCULAR INJURY | NEPHROTOXIC SERUM | PROTEIN-C ACTIVATION | CARBOXYPEPTIDASE-N | DISSEMINATED INTRAVASCULAR COAGULATION | UROLOGY & NEPHROLOGY | Thrombosis - chemically induced | Rats, Wistar | Thrombosis - complications | Blood Urea Nitrogen | Humans | Prothrombin Time | Carboxypeptidase B2 - blood | Complement C5a - metabolism | Blood Coagulation | Kidney Glomerulus - metabolism | Female | Leukocyte Count | Glomerulonephritis - etiology | Disease Models, Animal | Lysine Carboxypeptidase - blood | Rabbits | Thrombomodulin - administration & dosage | Solubility | Rats | Kidney Glomerulus - pathology | Glomerulonephritis - drug therapy | Thrombosis - pathology | Animals | Platelet Count | Partial Thromboplastin Time | Anaphylatoxins - metabolism | Glomerulonephritis - pathology | Creatinine - blood | Thrombin - metabolism | Fibrin - metabolism
Journal Article
Clinica Chimica Acta, ISSN 0009-8981, 2006, Volume 371, Issue 1, pp. 124 - 129
Carboxypeptidase N is a plasma zinc metallocarboxypeptidase which is constitutively expressed in the liver and was identified as the enzyme responsible for...
Carboxypeptidase N | Inflammation | Anaphylatoxin inactivator | Kinetic assay | THERMAL-STABILITY | carboxypeptidase N | HUMAN PLASMA | SERUM | PROCARBOXYPEPTIDASE-U TAFI | DEFICIENCY | RESPECT | ENZYME | anaphylatoxin inactivator | inflammation | FIBRINOLYSIS INHIBITOR TAFI | MEDICAL LABORATORY TECHNOLOGY | kinetic assay | Inflammation - pathology | Reproducibility of Results | Anaphylatoxins - antagonists & inhibitors | Humans | Middle Aged | Chromatography, High Pressure Liquid | Inflammation - blood | Anaphylatoxins - metabolism | Sensitivity and Specificity | Adolescent | Adult | Biological Assay | Aged | Dipeptides - metabolism | Kinetics | Lysine Carboxypeptidase - blood | Enzymes | Bradykinin | Immunoproteins
Carboxypeptidase N | Inflammation | Anaphylatoxin inactivator | Kinetic assay | THERMAL-STABILITY | carboxypeptidase N | HUMAN PLASMA | SERUM | PROCARBOXYPEPTIDASE-U TAFI | DEFICIENCY | RESPECT | ENZYME | anaphylatoxin inactivator | inflammation | FIBRINOLYSIS INHIBITOR TAFI | MEDICAL LABORATORY TECHNOLOGY | kinetic assay | Inflammation - pathology | Reproducibility of Results | Anaphylatoxins - antagonists & inhibitors | Humans | Middle Aged | Chromatography, High Pressure Liquid | Inflammation - blood | Anaphylatoxins - metabolism | Sensitivity and Specificity | Adolescent | Adult | Biological Assay | Aged | Dipeptides - metabolism | Kinetics | Lysine Carboxypeptidase - blood | Enzymes | Bradykinin | Immunoproteins
Journal Article
1995, ISBN 9780121821494, Volume 248, Issue C
Book Chapter
Clinical Chemistry, ISSN 0009-9147, 06/1999, Volume 45, Issue 6, pp. 807 - 813
Background: Procarboxypeptidase U (proCPU) is a novel proenzyme found in human plasma. The active form, carboxypeptidase U (CPU; EC 3.4.17.20), retards the...
HUMAN-SERUM | CARBOXYPEPTIDASE-N | THROMBIN | ARGININE CARBOXYPEPTIDASE | IN-VIVO | PURIFICATION | TAFI | COAGULATION | CLOT LYSIS | MEDICAL LABORATORY TECHNOLOGY | PLASMINOGEN | Reproducibility of Results | Humans | Middle Aged | Male | Reference Values | Thrombin | Chromatography, High Pressure Liquid | Fibrinolysis | Carboxypeptidases - blood | Sensitivity and Specificity | Carboxypeptidase B2 | Adult | Female | Aged | Enzyme Activation | Thrombomodulin | Enzymes | Fibrin | Lysine
HUMAN-SERUM | CARBOXYPEPTIDASE-N | THROMBIN | ARGININE CARBOXYPEPTIDASE | IN-VIVO | PURIFICATION | TAFI | COAGULATION | CLOT LYSIS | MEDICAL LABORATORY TECHNOLOGY | PLASMINOGEN | Reproducibility of Results | Humans | Middle Aged | Male | Reference Values | Thrombin | Chromatography, High Pressure Liquid | Fibrinolysis | Carboxypeptidases - blood | Sensitivity and Specificity | Carboxypeptidase B2 | Adult | Female | Aged | Enzyme Activation | Thrombomodulin | Enzymes | Fibrin | Lysine
Journal Article
Biomeditsinskaia khimiia, ISSN 2310-6972, 03/2016, Volume 62, Issue 2, p. 141
This review considers the basic metallocarboxypeptidases of human blood and their role in coagulologic disorders. In includes information on the history of the...
Blood Coagulation Disorders - enzymology | Lysine Carboxypeptidase - chemistry | Carboxypeptidases - blood | Humans | Lysine Carboxypeptidase - metabolism | Carboxypeptidases - metabolism | Blood Coagulation Disorders - diagnosis | Blood Coagulation - physiology | Fibrinolysis - physiology | Fibrin - metabolism | Carboxypeptidase B2 - chemistry | Carboxypeptidase B2 - metabolism
Blood Coagulation Disorders - enzymology | Lysine Carboxypeptidase - chemistry | Carboxypeptidases - blood | Humans | Lysine Carboxypeptidase - metabolism | Carboxypeptidases - metabolism | Blood Coagulation Disorders - diagnosis | Blood Coagulation - physiology | Fibrinolysis - physiology | Fibrin - metabolism | Carboxypeptidase B2 - chemistry | Carboxypeptidase B2 - metabolism
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 1989, Volume 162, Issue 3, pp. 933 - 939
An unstable carboxypeptidase N or B like enzyme is generated as a result of coagulation. This enzyme is derived from some plasma component (s) and not from...
BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOPHYSICS | Arginine | Carboxypeptidases - blood | Enzyme-Linked Immunosorbent Assay | Lysine | Humans | Blood Coagulation | Substrate Specificity | Inflammation - enzymology | Chromatography | Lysine Carboxypeptidase - blood
BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOPHYSICS | Arginine | Carboxypeptidases - blood | Enzyme-Linked Immunosorbent Assay | Lysine | Humans | Blood Coagulation | Substrate Specificity | Inflammation - enzymology | Chromatography | Lysine Carboxypeptidase - blood
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 09/2004, Volume 11, Issue 17, pp. 2335 - 2348
The coagulation system is a potent mechanism that prevents blood loss after vascular injury. It consists of a number of linked enzymatic reactions resulting in...
CPB | CPR | Coagulation | TAFI | CPU | Carboxypeptidase | Fibrinolysis | CHEMISTRY, MEDICINAL | PLASMA PROCARBOXYPEPTIDASE-B | BIOCHEMISTRY & MOLECULAR BIOLOGY | JUGULAR-VEIN THROMBOLYSIS | PROTEIN-C | coagulation | carboxypeptidase | fibrinolysis | 3-DIMENSIONAL STRUCTURE | TAFI ANTIGEN LEVELS | TYPE-2 DIABETIC-PATIENTS | TISSUE-PLASMINOGEN-ACTIVATOR | FACTOR-XI | CARBOXYPEPTIDASE-B | PHARMACOLOGY & PHARMACY | CLOT LYSIS | Humans | Carboxypeptidase B2 - blood | Hemorrhagic Disorders - blood | Thrombomodulin - chemistry | Thrombomodulin - metabolism | Animals | Carboxypeptidase B2 - physiology | Thrombin - chemistry | Fibrinogen - metabolism | Blood Coagulation Disorders - blood | Fibrinolysis - physiology | Thrombin - metabolism | Lysine - chemistry | Fibrinolysin - metabolism
CPB | CPR | Coagulation | TAFI | CPU | Carboxypeptidase | Fibrinolysis | CHEMISTRY, MEDICINAL | PLASMA PROCARBOXYPEPTIDASE-B | BIOCHEMISTRY & MOLECULAR BIOLOGY | JUGULAR-VEIN THROMBOLYSIS | PROTEIN-C | coagulation | carboxypeptidase | fibrinolysis | 3-DIMENSIONAL STRUCTURE | TAFI ANTIGEN LEVELS | TYPE-2 DIABETIC-PATIENTS | TISSUE-PLASMINOGEN-ACTIVATOR | FACTOR-XI | CARBOXYPEPTIDASE-B | PHARMACOLOGY & PHARMACY | CLOT LYSIS | Humans | Carboxypeptidase B2 - blood | Hemorrhagic Disorders - blood | Thrombomodulin - chemistry | Thrombomodulin - metabolism | Animals | Carboxypeptidase B2 - physiology | Thrombin - chemistry | Fibrinogen - metabolism | Blood Coagulation Disorders - blood | Fibrinolysis - physiology | Thrombin - metabolism | Lysine - chemistry | Fibrinolysin - metabolism
Journal Article